HSD17B4 and breast cancer: Zhang et al. [47] concluded that their study was the first to reveal a crosstalk between acetylation and CMA degradation in HSD17B4 regulation, the role of SIRT3, and the critical role of this regulation in the malignant progression of breast cancer.